UnitedHealth Group Incorporated
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $472.18
- Today's High:
- $483.64
- Open Price:
- $477.38
- 52W Low:
- $442.1603
- 52W High:
- $550.0319
- Prev. Close:
- $479.38
- Volume:
- 1607860
Company Statistics
- Market Cap.:
- $444.05 billion
- Book Value:
- 88.838
- Revenue TTM:
- $348.52 billion
- Operating Margin TTM:
- 8.75%
- Gross Profit TTM:
- $79.62 billion
- Profit Margin:
- 6.06%
- Return on Assets TTM:
- 7.47%
- Return on Equity TTM:
- 25.07%
Company Profile
UnitedHealth Group Incorporated had its IPO on 1984-10-26 under the ticker symbol UNH.
The company operates in the Healthcare sector and Healthcare Plans industry. UnitedHealth Group Incorporated has a staff strength of 400,000 employees.
Stock update
Shares of UnitedHealth Group Incorporated opened at $477.38 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $472.18 - $483.64, and closed at $479.9.
This is a +0.11% increase from the previous day's closing price.
A total volume of 1,607,860 shares were traded at the close of the day’s session.
In the last one week, shares of UnitedHealth Group Incorporated have increased by +1.16%.
UnitedHealth Group Incorporated's Key Ratios
UnitedHealth Group Incorporated has a market cap of $444.05 billion, indicating a price to book ratio of 6.7387 and a price to sales ratio of 1.5646.
In the last 12-months UnitedHealth Group Incorporated’s revenue was $348.52 billion with a gross profit of $79.62 billion and an EBITDA of $33.30 billion. The EBITDA ratio measures UnitedHealth Group Incorporated's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, UnitedHealth Group Incorporated’s operating margin was 8.75% while its return on assets stood at 7.47% with a return of equity of 25.07%.
In Q2, UnitedHealth Group Incorporated’s quarterly earnings growth was a positive 9% while revenue growth was a positive 15.6%.
UnitedHealth Group Incorporated’s PE and PEG Ratio
- Forward PE
- 21.5983
- Trailing PE
- 21.4584
- PEG
- 1.6567
Its diluted EPS in the last 12-months stands at $22.34 per share while it has a forward price to earnings multiple of 21.5983 and a PEG multiple of 1.6567. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into UnitedHealth Group Incorporated’s profitability.
UnitedHealth Group Incorporated stock is trading at a EV to sales ratio of 1.626 and a EV to EBITDA ratio of 16.8183. Its price to sales ratio in the trailing 12-months stood at 1.5646.
UnitedHealth Group Incorporated stock pays annual dividends of $6.83 per share, indicating a yield of 1.47% and a payout ratio of 30%.
Balance sheet and cash flow metrics
- Total Assets
- $280.16 billion
- Total Liabilities
- $112.98 billion
- Operating Cash Flow
- $-11748000000.00
- Capital Expenditure
- $829 million
- Dividend Payout Ratio
- 30%
UnitedHealth Group Incorporated ended 2024 with $280.16 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $280.16 billion while shareholder equity stood at $87.37 billion.
UnitedHealth Group Incorporated ended 2024 with $2.50 billion in deferred long-term liabilities, $112.98 billion in other current liabilities, 9000000.00 in common stock, $89.99 billion in retained earnings and $101.67 billion in goodwill. Its cash balance stood at $46.28 billion and cash and short-term investments were $46.28 billion. The company’s total short-term debt was $6,321,000,000 while long-term debt stood at $59.27 billion.
UnitedHealth Group Incorporated’s total current assets stands at $89.87 billion while long-term investments were $45.99 billion and short-term investments were $46.28 billion. Its net receivables were $17.95 billion compared to accounts payable of $31.95 billion and inventory worth $0.
In 2024, UnitedHealth Group Incorporated's operating cash flow was $-11748000000.00 while its capital expenditure stood at $829 million.
Comparatively, UnitedHealth Group Incorporated paid $0.30 in dividends in 2024.
Other key metrics
- Current Trading Price
- $479.9
- 52-Week High
- $550.0319
- 52-Week Low
- $442.1603
- Analyst Target Price
- $576.43
UnitedHealth Group Incorporated stock is currently trading at $479.9 per share. It touched a 52-week high of $550.0319 and a 52-week low of $550.0319. Analysts tracking the stock have a 12-month average target price of $576.43.
Its 50-day moving average was $489.31 and 200-day moving average was $489.37 The short ratio stood at 2.06 indicating a short percent outstanding of 0%.
Around 27.1% of the company’s stock are held by insiders while 8899.1% are held by institutions.
Frequently Asked Questions About UnitedHealth Group Incorporated
Similar Industry Stocks (Healthcare Plans)
Most Active
Top Gainers
Top Losers
About
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The OptumHealth segment provides care delivery, care management, wellness and consumer engagement, and health financial services for consumers, care delivery systems, providers, employers, payers, and public-sector entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.